This treatment adherence background information document has been prepared by Shire Pharmaceuticals and is for medical media only Non-adherence is a widespread, global problem in patients suffering from  chronic diseases and in developed countries adherence averages only 50%.1 

Results from a new post-hoc analysis of the landmark RE-LY®i trial show that in patients experiencing a major bleeding event, treatment with Pradaxa® (dabigatran etexilate) was associated with lower mortality and a shorter length of stay in intensive care compared to warfarin. 

Non-adherence is a widespread, global problem in patients suffering from chronic diseases and in developed countries adherence averages only 50%.1

        Accu-Chek Aviva Expert – what is it about?

A new treatment option for chronic constipation in women in whom laxatives have failed Malta, 15th June 2012 – Vivian Corporation, local partners of Shire plc (LSE: SHP, NASDAQ: SHPGY), the global specialty biopharmaceutical company, today announced that Resolor® (prucalopride) is now available in Malta and…

All Pharmacies in Gozo Participating in Week-Long Campaign

Marine Sourced Docosahexaenoic acid (DHA) Supplementation Improves Children’s Sleep1.

Vivian Corporation’s annual Wilfred Gatt Football Charity Tournament, held on 19th March, raised funds for a non-profit organisation, Maya Universe Academy in Nepal. MUA provides free education to children in rural Nepal.

  Independent Studies Proving Once Again that EPO Significantly Improves Symptoms of Atopic Eczema 1.

 High Omega-3 Status reduces brain white matter lesions associated with Cognitive Decline 1.

When it comes to health and nutrition, one size does not always fit all. Centrum, the World`s No. 1 Multivitamin, has 30 years of expertise and has now reached a new level with the introduction of advanced formulas which are gender and age adjusted. Centrum…